Medtech maker Medrobotics celebrated the world’s 1st cancer surgeries performed with its Flex surgical robot in a pair of procedures conducted at a hospital in Germany.
Massachusetts-based Medrobotics raised $26 million in a Series E fundraising round in support of its Flex surgical robot.
The company said it plans to use the new funds to launch commercial efforts in the U.S. and in Europe, as well as in pursuit of new regulatory bids. The company has European approval for the Flex system, but has not yet won a nod from the FDA.
By Jeffrey Holt
Massachusetts medical device maker Medrobotics won CE Mark approval in the European Union for its Flex System, a robot-assisted surgical device indicated for use in otolaryngology surgery.
Class I recalls
Recalling Manufacturer, Date Posted, Trade Name/Product, Reason for Recall
AngioDynamics loses EVP & CFO
Albany, N.Y.-based AngioDynamics’ executive vice president & CFO Joseph Gersuk retired from the company, effective January 31, 2013.
Cook Medical launched its 10th clinical division last weekend with a pair of products aimed at the ear, nose & throat market.
Thomas Cherry, head of Cook’s new otolaryngology/head & neck surgery division, told MassDevice.com that the segment already has a salivary stone removal system and an endoscopic balloon treatment for dysphasia cleared for the markets in the U.S. and Europe.
Sound waves produce the sensation of hearing by vibrating hair-like structures on the inner ear’s sensory hair cells. But how this mechanical motion gets converted into electrical signals that go to our brains has long been a mystery.